Videos

Never Ever Ever Give Up

August 29th 2022

Expert Breaks Down Immunotherapy Options in Kidney Cancer

August 25th 2022

In recent years, immunotherapy’s usage has expanded for the treatment of patients with kidney cancer.

An Expert’s Experience in Prescribing Tebentafusp and Other Therapies for mUM and a Commentary on Patient Education and Resources

August 24th 2022

Dr Sunandana Chandra highlights her personal experience in prescribing tebentafusp and other therapies for mUM, and discusses the educational resources and advocacy organizations that she encourages patients to look into to help make an informed decision about their treatment regimens.

Patient Eligibility and Logistical and Safety Considerations for Tebentafusp Treatment in mUM

August 24th 2022

An oncologist outlines which patients with mUM are eligible for bispecific T-cell receptor immunotherapy, discusses logistical and safety considerations, and explains why pre-treatment HLA testing is required for those considering the regimen.

Implications of Clinical Trial Data on Bispecific T-Cell Receptor Immunotherapy for mUM

August 18th 2022

Sunandana Chandra, MD, MS, discusses safety and efficacy data from the IMCgp100-202 trial on tebentafusp, and comments on the clinical implications of these data.

Historic and Current Treatment Options for mUM

August 18th 2022

An expert provides an overview of the historical and currently available treatment options in metastatic uveal melanoma (mUM), including the bispecific T-cell receptor immunotherapy tebentafusp (“teh-BEN-tah-fuhsp”).

Patients With Cancer Should Speak Up About Mental Health Struggles if They Don’t Feel Heard, Expert Says

August 15th 2022

A psychiatrist advises patients with cancer to speak up about their mental health concerns during cancer treatment, as there are tools that can guide best next steps.

Support and Advice for Patients with mCRPC and Their Caregivers

August 11th 2022

Joseph Wood and his caregiver, Deborah Wood, provide advice for patients and caregivers with prostate cancer who may be in similar situations, and comment on the support they have received from their family and community.

Common Symptoms of Uveal Melanoma and the Typical Diagnostic Journey of the Patient

August 10th 2022

Dr Sunandana Chandra describes the typical symptoms that patients with uveal melanoma experience, the prevalent asymptomatic patient population, and how optometrists and ophthalmologists may be involved in the diagnostic process.

How Uveal Melanoma Differs from Cutaneous Melanoma

August 10th 2022

Sunandana Chandra, MD, MS, explains how uveal melanoma is different from cutaneous melanoma, including prevalence, molecular mutations, and survival prognosis after metastasis.

Expert Advises Patients With Breast Cancer They Can Forgo Certain Supplements

August 10th 2022

Many patients with breast cancer ask about the benefits of the supplement sulforaphane, but a naturopathic doctor advises patients that it is best to get the compound from food rather than supplements.

Follow-up and Side Effects in Patients Treated with Lutetium 177-PSMA 167

August 8th 2022

Joseph Wood and his wife and caregiver, Deborah, share their concerns and questions about radioligand therapy and how the COVID-19 pandemic has impacted their treatment experience.

Genetic Testing May 'Open New Doors for New Treatments' in Prostate Cancer

August 4th 2022

In this video, an expert discusses which men with prostate cancer are eligible for genetic testing, and what patients can do if they are not eligible but want to undergo testing anyway.

Outcomes Are Best When Patients With Cancer Are as Aware of Their Disease as Their Provider, Expert Says

August 2nd 2022

Patients with cancer are encouraged to learn more about their disease from evidenced-based sources and not “Dr. Google.”

Clinical Considerations Related to Lutetium 177– PSMA-617 Treatment in mCRPC

August 2nd 2022

Dr Jeremie Calais shares some clinical pearls for lutetium-177 PSMA 617 and how this therapy has changed the treatment landscape for patients with metastatic castration resistant prostate cancer (mCRPC).

A Multi-Disciplinary Approach to Treatment for Patients with mCRPC

August 2nd 2022

Drs Matthew Rettig and Jeremie Calais explain what it means to be a part of a collaborative team and how communication plays a big role in patients receiving optimal treatment.

Educated Patient® Lung Cancer Summit Looking Ahead Panel: June 25, 2022

July 29th 2022

Watch Dr. Ravi Salgia, Dr. Erminia Massarelli, Dr. Jyoti Malhotra and Daniel Saez answer questions about advancements in lung cancer during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Advancements in Advanced-Stage Non-Small Cell Lung Cancer Presentation: June 25, 2022

July 28th 2022

Watch Dr. Jyoti Malhotra, from City of Hope, discuss advancements in advanced-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Advancements in Early-Stage Non-Small Cell Lung Cancer Presentation: June 25, 2022

July 27th 2022

Watch Dr. Erminia Massarelli, from City of Hope, discuss advancements in early-stage non-small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

Treatment Journey Shared by a Patient with mCRPC and his Caregiver

July 26th 2022

Joseph Wood details his treatment journey with metastatic castration-resistant prostate cancer (mCRPC) and how the journey has impacted his wife and caregiver, Deborah Wood.

VISION Trial of Lutetium-177-PSMA-617 in mCRPC: Clinical Implications

July 26th 2022

Dr Jeremie Calais reviews the VISION trial and the implications of the data in the treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC).

Educated Patient® Lung Cancer Summit Advancements in Small Cell Lung Cancer Presentation: June 25, 2022

July 26th 2022

Watch Dr. Ravi Salgia, from City of Hope, discuss advancements in small cell lung cancer during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Overcoming Barriers to Receiving Biomarker Testing Panel: June 25, 2022

July 25th 2022

Watch Nikki Martin, Dr. Ying-Chun Lo and Dr. Hossein Borghaei discuss overcoming barriers to receiving biomarker testing during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Targeted Treatment Panel: June 25, 2022

July 24th 2022

Watch Elisabeth King, Dr. Edward S. Kim and Terri Conneran answer questions about targeted therapy during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Targeted Therapies Presentation: June 25, 2022

July 23rd 2022

Watch Dr. Edward S. Kim, from City of Hope, discuss targeted therapy during the CURE Educated Patient Lung Cancer Summit.

‘Listen to Your Patient,’ Says Cancer Caregiver

July 22nd 2022

A cancer caregiver recommends that other caregivers become well-versed in their loved one’s disease.

Educated Patient® Lung Cancer Summit Biomarker Testing Presentation: June 25, 2022

July 22nd 2022

Watch Elisabeth King, from City of Hope, discuss biomarker testing during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Basics of the Disease Panel: June 25, 2022

July 21st 2022

Watch Dr. Farhad Mazdisnian, Dr. Terence Williams and Dr. Antoinette J. Wozniak answer questions about the basics of the disease during the CURE Educated Patient Lung Cancer Summit.

Educated Patient® Lung Cancer Summit Radiation Advances Presentation: June 25, 2022

July 20th 2022

Watch Dr. Terrance M. Williams, from City of Hope, discuss radiation advances during the CURE Educated Patient Lung Cancer Summit.

Educated Patient®: An Insightful Look at GIST and Available Treatment Options

July 19th 2022